Narrow Band Imaging in Flexible Cystocopy

Patients with first time hematuria or patients previously diagnosed with papillomas/CIS of the bladder are included in the study. All surgeons are highly experienced in WL cystoscopy and familiar with NBI findings. Cystoscopy is performed with HD cameras and Olympus light sources.

First, a systematic cystoscopy is made in WL. Secondly, the clinical decision is noted. After WL, the cystoscopy is made with NBI and any potential subsequent change in the clinical decision is noted.

A total number of 896 patients is planned to be included.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Narrow Band Imaging in Flexible Cystoscopy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Herlev Hospital, Herlev, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing flexible cystoscopy because of haematuria or previous NMIBC

Exclusion criteria

Patients not fullfilling the above

Treatment and study plan

Primary outcomes

change in the clinical decision

Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Aarhus University Hospital

Other

Collaborators

Herlev Hospital
Hospitalsenheden Vest
Oslo University Hospital

Registry information

Official study title

Narrow Band Imaging in Flexible Cystocopy - DaBlaCa-7

Acronym: DaBlaCa-7

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Dec 10, 2014
Registry last updated: May 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.